CS

Chandan Sai Karakavalasa

Active Director Designated Partner DIN 08903973
DIN 08903973 First appointment Oct 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandan Sai Karakavalasa

Data last updated:

Chandan Sai Karakavalasa is a Designated Partner at Cure House Innovative Solutions Llp (since 2020). The company operates in Healthcare.

DIN 08903973
Primary Designation Designated Partner
Industry Healthcare
First Appointment 05 Oct 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Oct 20202020Active

Board colleagues of Chandan Sai Karakavalasa

NameDINCompanyDesignation
Jami Raviteja08903932Cure House Innovative Solutions LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cure House Innovative Solutions Llp
Premium access

Shareholding and investment profile for Chandan Sai Karakavalasa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandan Sai Karakavalasa

Chandan Sai Karakavalasa currently holds 1 directorship: Cure House Innovative Solutions Llp (Designated Partner, since 05 Oct 2020).

Chandan Sai Karakavalasa was first appointed on 05 Oct 2020 as Designated Partner at Cure House Innovative Solutions Llp.

The current boards of Chandan Sai Karakavalasa's companies include Jami Raviteja (Cure House Innovative Solutions Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available